Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2012 (2012), Article ID 875742, 10 pages
http://dx.doi.org/10.1155/2012/875742
Research Article

Differential Expression of Matrix Metalloproteases in Human Fibroblasts with Different Origins

Department of Cardiology and Pneumology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany

Received 1 September 2011; Accepted 25 November 2011

Academic Editor: Maria L. Urso

Copyright © 2012 Diana Lindner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. D. Brown, S. K. Ambler, M. D. Mitchell, and C. S. Long, “The cardiac fibroblast: therapeutic target in myocardial remodeling and failure,” Annual Review of Pharmacology and Toxicology, vol. 45, pp. 657–687, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. H. K. Graham, M. Horn, and A. W. Trafford, “Extracellular matrix profiles in the progression to heart failure: European young physiologists symposium keynote lecture-bratislava 2007,” Acta Physiologica, vol. 194, no. 1, pp. 3–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. E. Porter and N. A. Turner, “Cardiac fibroblasts: at the heart of myocardial remodeling,” Pharmacology and Therapeutics, vol. 123, no. 2, pp. 255–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. F. G. Spinale, “Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function,” Physiological Reviews, vol. 87, no. 4, pp. 1285–1342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. F. G. Spinale, M. L. Coker, B. R. Bond, and J. L. Zellner, “Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target,” Cardiovascular Research, vol. 46, no. 2, pp. 225–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. S. P. Zhong, Y. Z. Zhang, and C. T. Lim, “Tissue scaffolds for skin wound healing and dermal reconstruction,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 2, no. 5, pp. 510–525, 2010. View at Publisher · View at Google Scholar
  7. I. Banerjee, J. W. Fuseler, R. L. Price, T. K. Borg, and T. A. Baudino, “Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse,” American Journal of Physiology, vol. 293, no. 3, pp. H1883–H1891, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Banerjee, K. Yekkala, T. K. Borg, and T. A. Baudino, “Dynamic interactions between myocytes, fibroblasts, and extracellular matrix,” Annals of the New York Academy of Sciences, vol. 1080, pp. 76–84, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. E. C. Goldsmith, A. Hoffman, M. O. Morales et al., “Organization of fibroblasts in the heart,” Developmental Dynamics, vol. 230, no. 4, pp. 787–794, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. G. M. Roomans, “Tissue engineering and the use of stem/progenitor cells for airway epithelium repair,” European Cells & Materials, vol. 19, pp. 284–299, 2010. View at Google Scholar · View at Scopus
  11. J. Kukacka, R. Průsa, K. Kotaska, and V. Pelouch, “Matrix metalloproteinases and their function in myocardium,” Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, vol. 149, no. 2, pp. 225–236, 2005. View at Google Scholar
  12. F. J. Villarreal, M. Griffin, J. Omens, W. Dillmann, J. Nguyen, and J. Covell, “Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling,” Circulation, vol. 108, no. 12, pp. 1487–1492, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. N. A. Turner, R. S. Mughal, P. Warburton, D. J. O'Regan, S. G. Ball, and K. E. Porter, “Mechanism of TNFα-induced IL-1α, IL-1β and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones,” Cardiovascular Research, vol. 76, no. 1, pp. 81–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Breen, V. M. Falco, M. Absher, and K. R. Cutroneo, “Subpopulations of rat lung fibroblasts with different amounts of type I and type III collagen mRNAs,” Journal of Biological Chemistry, vol. 265, no. 11, pp. 6286–6290, 1990. View at Google Scholar · View at Scopus
  15. H. Okada, S. Ban, S. Nagao, H. Takahashi, H. Suzuki, and E. G. Neilson, “Progressive renal fibrosis in routine polycystic kidney disease: an immunohistochemical observation,” Kidney International, vol. 58, no. 2, pp. 587–597, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Jelaska, D. Strehlow, and J. H. Korn, “Fibroblast heterogeneity in physiological conditions and fibrotic disease,” Springer Seminars in Immunopathology, vol. 21, no. 4, pp. 385–395, 1999. View at Google Scholar · View at Scopus
  17. H. Y. Chang, J. T. Chi, S. Dudoit et al., “Diversity, topographic differentiation, and positional memory in human fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 20, pp. 12877–12882, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Thum, C. Gross, J. Fiedler et al., “MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts,” Nature, vol. 456, no. 7224, pp. 980–984, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Yano, T. Miura, Y. Ikeda et al., “Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair,” Cardiovascular Pathology, vol. 14, no. 5, pp. 241–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Wong, J. A. McGrath, and H. Navsaria, “The role of fibroblasts in tissue engineering and regeneration,” British Journal of Dermatology, vol. 156, no. 6, pp. 1149–1155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. van Amerongen and F. B. Engel, “Features of cardiomyocyte proliferation and its potential for cardiac regeneration: stem cells review series,” Journal of Cellular and Molecular Medicine, vol. 12, no. 6A, pp. 2233–2244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. von Haehling, E. A. Jankowska, and S. D. Anker, “Tumour necrosis factor-α and the failing heart: pathophysiology and therapeutic implications,” Basic Research in Cardiology, vol. 99, no. 1, pp. 18–28, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. L. A. Cooker, D. Peterson, J. Rambow et al., “TNF-α, but not IFN-γ, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis,” American Journal of Physiology, vol. 293, no. 1, pp. F157–F165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Roman-Blas, D. G. Stokes, and S. A. Jimenez, “Modulation of TGF-β signaling by proinflammatory cytokines in articular chondrocytes,” Osteoarthritis and Cartilage, vol. 15, no. 12, pp. 1367–1377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Mauviel, M. Daireaux, F. Redini, P. Galera, G. Loyau, and J. P. Pujol, “Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts,” FEBS Letters, vol. 236, no. 1, pp. 47–52, 1988. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Chizzolini, Y. Parel, C. De Luca et al., “Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor α,” Arthritis and Rheumatism, vol. 48, no. 9, pp. 2593–2604, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. D. J. Kouba, K. Y. Chung, T. Nishiyama et al., “Nuclear factor-κB mediates TNF-α inhibitory effect on α2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts,” Journal of Immunology, vol. 162, no. 7, pp. 4226–4234, 1999. View at Google Scholar · View at Scopus
  28. F. Verrecchia, E. F. Wagner, and A. Mauviel, “Distinct involvement of the Jun-N-terminal kinase and NF-κB pathways in the repression of the human COL1A2 gene by TNF-α,” EMBO Reports, vol. 3, no. 11, pp. 1069–1074, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Verrecchia, M. Pessah, A. Atfi, and A. Mauviel, “Tumor necrosis factor-α inhibits transforming growth factor-β/Smad signaling in human dermal fibroblasts via AP-1 activation,” Journal of Biological Chemistry, vol. 275, no. 39, pp. 30226–30231, 2000. View at Google Scholar · View at Scopus
  30. L. Zhou, C. Yan, R. G. Gieling et al., “Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1,” BMC Immunology, vol. 10, article 15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J.-M. Dayer, B. Beutler, and A. Cerami, “Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts,” Journal of Experimental Medicine, vol. 162, no. 6, pp. 2163–2168, 1985. View at Google Scholar
  32. T. E. Cawston, V. A. Curry, I. M. Clark, and B. L. Hazleman, “Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase,” Biochemical Journal, vol. 269, no. 1, pp. 183–187, 1990. View at Google Scholar · View at Scopus
  33. G. Murphy, M. I. Cockett, P. E. Stephens, B. J. Smith, and A. J. P. Docherty, “Stromelysin is an activator of procollagenase: a study with natural and recombinant enzymes,” Biochemical Journal, vol. 248, no. 1, pp. 265–268, 1987. View at Google Scholar · View at Scopus
  34. K. Wisithphrom and L. J. Windsor, “The effects of tumor necrosis factor-α, interleukin-1β, interleukin-6, and transforming growth factor-β1 on pulp fibroblast mediated collagen degradation,” Journal of Endodontics, vol. 32, no. 9, pp. 853–861, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Wisithphrom, P. E. Murray, and L. J. Windsor, “Interleukin-1 α alters the expression of matrix metalloproteinases and collagen degradation by pulp fibroblasts,” Journal of Endodontics, vol. 32, no. 3, pp. 186–192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. A. J. H. Gearing, P. Beckett, M. Christodoulou et al., “Matrix metalloproteinases and processing of pro-TNF-α,” Journal of Leukocyte Biology, vol. 57, no. 5, pp. 774–777, 1995. View at Google Scholar · View at Scopus
  37. S. E. Gill and W. C. Parks, “Metalloproteinases and their inhibitors: regulators of wound healing,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 6-7, pp. 1334–1347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Dobaczewski, C. Gonzalez-Quesada, and N. G. Frangogiannis, “The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 48, no. 3, pp. 504–511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. G. A. McQuibban, J. H. Gong, E. M. Tam, C. A. G. McCulloch, I. Clark-Lewis, and C. M. Overall, “Inflammation dampened by gelatinase a cleavage of monocyte chemoattractant protein-3,” Science, vol. 289, no. 5482, pp. 1202–1206, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Westermann, K. Savvatis, D. Lindner et al., “Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy,” Circulation, vol. 124, no. 19, pp. 2082–2093, 2011. View at Publisher · View at Google Scholar
  41. P. Brenneisen, H. Sies, and K. Scharffetter-Kochanek, “Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events,” Annals of the New York Academy of Sciences, vol. 973, pp. 31–43, 2002. View at Google Scholar · View at Scopus
  42. V. M. Kähäri and U. Saarialho-Kere, “Matrix metalloproteinases in skin,” Experimental Dermatology, vol. 6, no. 5, pp. 199–213, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Lukes, S. Mun-Bryce, M. Lukes, and G. A. Rosenberg, “Extracellular matrix degradation by metalloproteinases and central nervous system diseases,” Molecular Neurobiology, vol. 19, no. 3, pp. 267–284, 1999. View at Google Scholar · View at Scopus